Results 101 to 110 of about 546 (157)

In vitro activity of tedizolid (TR-700) against linezolid-resistant staphylococci

, 2012
Objectives: To compare the activity of tedizolid (formally known as torezolid and TR-700) with that of 15 agents against a collection of linezolid-resistant staphylococci (164 coagulase-negative staphylococci and 5 Staphylococcus aureus).
Morales Kucharski, María Gracia, Pena, Irene, Rodríguez-Avial, Icíar, Culebras, Esther, Picazo, Juan José, Betriu, Carmen   +5 more
core   +1 more source

Surveillance of tedizolid activity and resistance: In vitro susceptibility of Gram-positive pathogens collected over 5 years from the United States and Europe

, 2017
In vitro activity of tedizolid and comparators against 11,231 Gram-positive clinical isolates from the United States (84 centers) and Europe (115 centers) were summarized as part of the Surveillance of Tedizolid Activity and Resistance program between ...
Bensaci, Mekki, Sahm, Daniel
core   +1 more source

Tedizolid phosphate for the management of acute bacterial skin and skin structure infections: safety summary

, 2014
The novel oxazolidinone tedizolid phosphate is in late-stage clinical development. In an effort to improve efficacy and safety, the adverse event profile and safety aspects of tedizolid phosphate have been evaluated in several preclinical animal models ...
Prokocimer, Philippe, Das, Debaditya, Fang, Edward, Mehra, Purvi, Tulkens, Paul M.   +4 more
core   +1 more source

Tedizolid phosphate for the treatment of acute bacterial skin and skin-structure infections: an evidence-based review of its place in therapy

, 2019
Introduction: Tedizolid phosphate is an oxazolidinone approved for the treatment of acute bacterial skin and skin-structure infections (ABSSSIs) and active against methicillin-resistant Staphylococcus aureus.
Bassetti M, Castaldo N, Giacobbe DR, Castaldo, Nadia, Peghin M, Carnelutti, Alessia, Bassetti, Matteo, Peghin, Maddalena, Giacobbe, Daniele Roberto, Carnelutti A   +9 more
core   +1 more source

Analysis of the phase 3 ESTABLISH trials of tedizolid versus linezolid in acute bacterial skin and skin structure infections.

, 2015
Tedizolid, a novel oxazolidinone with activity against a wide range of Gram-positive pathogens, was evaluated in two noninferiority phase 3 acute bacterial skin and skin structure infection trials.
Prokocimer, Philippe, Shorr, Andrew F, De Anda, Carisa, Das, Anita F, Fang, Edward, Corey, G Ralph, Lodise, Thomas P   +6 more
core   +1 more source

Tedizolid ve Omadasiklin’nin Tüberküloz Dışı Mikobakterilere karşı in vitro etkinliğinin araştırılması

, 2023
Tüberküloz Dışı Mikobakteriler (TDM), çevrede her yerde özellikle toprak ve su kaynaklarında bulunan, fırsatçı patojenlerdir. Tüberküloz Dışı Mikobakteri kaynaklı enfeksiyonlara karşı uygun ilaç rejimlerinin oluşturulabilmesi için antibiyotik ...
Özçatalkaya, Nazlı Ece, Çiftçi, Elif, Şatana, Dilek, Türkkal, Seda, Yaman, Görkem   +4 more
core  

Tedizolid for Treatment of Enterococcal Bacteremia [PDF]

Open Forum Infectious Diseases, 2016
Praveen Sudhindra, Leslie Lee, Guiqing Wang, Abhay Dhand   +3 more
openaire   +1 more source

Optic and peripheral neuropathy associated with short and prolonged administration of tedizolid: a review

Tedizolid is a novel antibiotic of the class of oxazolidinones. This review evaluates the published literature on the optic and peripheral neuropathy associated with short and prolonged administration of tedizolid.
Katsarou, Angeliki, Palioura, Sotiria, Tzikopoulou, Maria, Falagas, Matthew E, Papadopoulos, Dimitrios   +4 more
core   +1 more source

A tedizolid-foszfát (Sivextro®) in vitro hatékonyságának vizsgálata methicillin rezisztens Staphylococcus aureus (MRSA) törzseken

, 2016
A dolgozatomban egy új antibiotikum, a tedizolid hatását vizsgáltam MRSA baktériumokon. A methicillin rezisztens Staphylococcus aureus nagyon elterjedt baktérium és számos kórképet idéz elő.
Nagy, Jolán Erika
core  

LC-MS/MS Method for Simultaneous Quantification of Three Oxazolidinone Antimicrobials in Human Plasma: Application to Therapeutic Drug Monitoring

Drug Design, Development and Therapy
Na Zhang,* Nan Bai,* Ying Wang, Beibei Liang, Yun Cai Center of Medicine Clinical Research, Department of Pharmacy, Medical Supplies Center, PLA General Hospital, Beijing, 100853, People’s Republic of China*These authors ...
Zhang N, Bai N, Wang Y, Liang B, Cai Y
doaj